Clinical trial
Lesion Network Mapping-Navigated Continuous Theta-Burst Stimulation for Motor Recovery in Acute Ischemic Stroke: A Randomized, Double-Blind, Sham-Controlled, Multicentre Phase 3 Trial: MASTRE-3
NCT07645586 is registered in ClinicalTrials.gov with Beijing Tiantan Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Lesion Network Mapping-Navigated Continuous Theta-Burst Stimulation for Motor Recovery in Acute Ischemic Stroke: A Randomized, Double-Blind, Sham-Controlled, Multicentre Phase 3 Trial: MASTRE-3
- Lead sponsor
- Beijing Tiantan Hospital
- Phase
- Phase 3
- Overall status
- Not yet recruiting
- Start date
- October 1, 2026
- Completion date
- December 30, 2027
- Enrollment
- 584 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.